• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Rite Aid and Bartell Drugs Announce Availability of Appointments for Updated COVID-19 Vaccine

    9/15/23 3:15:00 PM ET
    $RAD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $RAD alert in real time by email

    Customers can now schedule appointments at Riteaid.com and Bartelldrugs.com

    Following FDA authorization and CDC recommendation, Rite Aid (NYSE:RAD) today announced that scheduling is now available for eligible customers seeking the updated COVID-19 (2023-2024) vaccines at its locations and at Bartell Drugs locations in the Pacific Northwest. Appointments are available beginning on Friday, September 22.

    "Rite Aid looks forward to providing our customers access to the updated COVID-19 (2023-2024) vaccine to safeguard the health and wellbeing of our communities heading into respiratory season," said Karen Staniforth, Chief Pharmacy Officer at Rite Aid. "We strongly encourage everyone to prepare by staying up to date on all recommended immunizations."

    The updated COVID-19 vaccine provides enhanced protection against currently circulating variants of COVID-19. The vaccine is recommended for individuals six months and older. An updated COVID-19 vaccine is needed for those who have not received a COVID-19 vaccine in the past two months, according to the CDC. Rite Aid pharmacists are trained to immunize customers ages three and older.

    Eligible Rite Aid customers may schedule an appointment at www.riteaid.com/pharmacy/scheduler. Bartell Drugs customers can use the online scheduling tool linked here. Other immunizations, including the flu vaccine, can also be scheduled via the online scheduling tool. Both the COVID-19 and flu vaccinations can be administered during the same appointment.

    About Rite Aid Corporation

    Rite Aid is a full-service pharmacy that improves health outcomes. Rite Aid is defining the modern pharmacy by meeting customer needs with a wide range of vehicles that offer convenience, including retail and delivery pharmacy, as well as services offered through our wholly owned subsidiaries, Elixir, Bartell Drugs and Health Dialog. Elixir, Rite Aid's pharmacy benefits and services company, consists of accredited mail and specialty pharmacies, prescription discount programs and an industry leading adjudication platform to offer superior member experience and cost savings. Health Dialog provides healthcare coaching and disease management services via live online and phone health services. Regional chain Bartell Drugs has supported the health and wellness needs in the Seattle area for more than 130 years. Rite Aid employs more than 6,300 pharmacists and operates more than 2,300 retail pharmacy locations across 17 states. For more information, visit www.riteaid.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230915954594/en/

    Get the next $RAD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RAD

    DatePrice TargetRatingAnalyst
    4/7/2022$16.00 → $1.00Hold → Sell
    Deutsche Bank
    6/25/2021$21.00 → $12.00Neutral → Underweight
    JP Morgan
    More analyst ratings

    $RAD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3: New insider Dupaul Christopher W. claimed ownership of 34,525 shares

      3 - RITE AID CORP (0000084129) (Issuer)

      8/24/23 4:33:34 PM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form 4 filed by Schroeder Matt

      4 - RITE AID CORP (0000084129) (Issuer)

      7/28/23 4:10:16 PM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form 4 filed by Mennen Justin L.

      4 - RITE AID CORP (0000084129) (Issuer)

      7/28/23 4:09:48 PM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $RAD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Carenet Health Acquiring Health Dialog, Enhancing Clinical Team and Advancing Insights-Driven Platform Dedicated to the Business of Healthcare

      Expanded personalized population health capabilities support better health journeys for patients Carenet Health, a trusted partner in helping organizations simplify and power the business of healthcare, is excited to announce it is acquiring Health Dialog, a worldwide leader in delivering clinical decision support offerings. This acquisition enables Carenet to leverage its combined platform, analytics and clinicians to deliver greater efficiency and outcomes-based financial performance for clients. Health Dialog provides personalized population health services to health plans, providers, employers and pharmaceutical manufacturers. Carenet is acquiring all assets of Health Dialog from

      3/6/24 11:05:00 AM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Rite Aid Receives Court Approval of "First Day" Motions to Support Business Operations

      Secures Interim Approval to Access Up to $3.45 Billion in Debtor-in-Possession Financing Continues to Serve Customers and Deliver Healthcare Products and Services Across Retail and Online Platforms Rite Aid Corporation (OTC:RADCQ) ("Rite Aid" or the "Company") today announced that it has received approvals from the U.S. Bankruptcy Court for the District of New Jersey for its "First Day" motions related to the Company's voluntary Chapter 11 petitions filed on October 15, 2023. The Court granted interim approval to access up to $3.45 billion in debtor-in-possession financing from certain of its lenders. This financing is expected to provide sufficient liquidity to support the Company th

      10/17/23 11:05:00 AM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Rite Aid Corporation Appoints Jeffrey S. Stein Chief Executive Officer

      Stein Succeeds Elizabeth "Busy" Burr Rite Aid Corporation (NYSE:RAD) ("Rite Aid" or the "Company") today announced that its Board of Directors has appointed Jeffrey S. Stein as Chief Executive Officer (CEO), Chief Restructuring Officer (CRO) and a member of the Board of Directors, effective immediately. Mr. Stein succeeds Elizabeth ("Busy") Burr, who has served as Interim CEO of Rite Aid since January 2023. Ms. Burr will continue to serve on the Company's Board. Mr. Stein brings more than three decades of experience as a leader and executive director at both public and private companies. Mr. Stein has particular expertise in supporting companies that are driving meaningful business tran

      10/15/23 10:37:00 PM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $RAD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Rite Aid downgraded by Deutsche Bank with a new price target

      Deutsche Bank downgraded Rite Aid from Hold to Sell and set a new price target of $1.00 from $16.00 previously

      4/7/22 7:32:45 AM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Rite Aid downgraded by JP Morgan with a new price target

      JP Morgan downgraded Rite Aid from Neutral to Underweight and set a new price target of $12.00 from $21.00 previously

      6/25/21 7:27:02 AM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Deutsche Bank reiterated coverage on Rite Aid with a new price target

      Deutsche Bank reiterated coverage of Rite Aid with a rating of Hold and set a new price target of $27.00 from $17.00 previously

      3/25/21 9:26:08 AM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $RAD
    SEC Filings

    See more
    • SEC Form NT 10-Q filed by Rite Aid Corporation

      NT 10-Q - RITE AID CORP (0000084129) (Filer)

      1/12/24 5:00:11 PM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Rite Aid Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Other Events, Financial Statements and Exhibits

      8-K - RITE AID CORP (0000084129) (Filer)

      12/27/23 6:03:09 AM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Rite Aid Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - RITE AID CORP (0000084129) (Filer)

      11/1/23 4:30:23 PM ET
      $RAD
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples